This study investigated the effects of Porphyra yezoensis enzyme degradation extract (PYEDE) on the brain injuries and neurodegenerative diseases due to oxidative stress. We used in vitro antioxidant systems to verify the antioxidant potential of PYEDE. The results indicated that PYEDE alleviated weight loss and organ atrophy, reduced the levels of lipid peroxidation and protein carbonylation, and elevated glutathione (GSH) content in the serum and brains of the D-gal-induced aging model mice. PYEDE also renewed the glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and total anti-oxidant capability (T-AOC) activities, downregulated the inducible nitric oxide synthase (iNOS) activity and nitric oxide (NO) levels, normalized the hippocampal neurons, and modulated multiple neurotransmitter systems by inhibiting the activities of acetylcholinesterase (AchE) and monoamine oxidase (MAO) in the upregulation of acetylcholine (Ach), dopamine (DA) and norepinephrine (NE)
pectinase, and 250 U/g cellulase) for 12 h under the conditions of solid-liquid ratio (water as solvent), hydrolysis temperature and pH of 1:40, 40 °C, and 6.0, respectively.
The mixture was centrifuged at 4800 rpm for 10 min, and the supernatant was collected and freeze-dried to obtain PYEDE. PYEDE was stored at −20 °C until further use.
The carbohydrate content in PYEDE was measured by the phenol-sulphuric acid method, and glucose was added as a standard (16) . The reducing sugar content was assayed using the 3,5-dinitrosalicylic acid (DNS) method and compared with the standard curve of D-galactose (17) . The protein content was estimated by the Kjeldahl method (18) . The ninhydrin method was used for the quantitative determination of amino acids (19) . The sulphuric radical content was evaluated by barium sulphate turbidimetry (20) . The uronic acid content was measured according to the reported method (21) . The Folin-Ciocalteu method was used to determine total phenolic compounds (22) .
In vitro determination of antioxidant activity of PYEDE

Assay of DPPH radical scavenging activity
The DPPH radical scavenging activity assay was carried out based on the reported procedure with slight modifications (23) . Briefly, the sample was prepared in deionized water to obtain various concentrations. Then 2 mL of a 2 mM methanol solution of DPPH was mixed with 2 mL of the sample. The solutions were fully mixed and Downloaded from https://www.cambridge.org/core. IP address: 54.70. 40 .11, on 13 Dec 2019 at 02:39:33, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114519003088
Accepted manuscript incubated at room temperature in the dark for 30 min. After which, the absorbance was measured by a 722S spectrophotometer (Shanghai Precision Instruments Co., Ltd., Shanghai, China) at 517 nm. VC was used as the positive control, and the DPPH radical scavenging ability was calculated according to the following equation:
DPPH radical scavenging activity (%)= 1-
Where A 0 is the absorbance of the control (methanol instead of the sample), A 1 is the absorbance of the sample, and A 2 is the absorbance of the sample under identical conditions as A 1 with methanol instead of DPPH solution.
Assay of ABTS radical scavenging activity
The scavenging activity toward ABTS was evaluated according to a published method (24) . The ABTS radical solution was formed by a 12 h reaction of ABTS (7 mM) with potassium persulfate (K 2 S 2 O 8 , 2.45 mM) at room temperature in the dark. The ABTS solution was diluted with PBS (0.2 M, pH 7.4) to create the working solution with an absorbance of 0.7 ± 0.02 at 734 nm. Then 2.4 mL of the ABTS working solution was mixed with 0.6 mL of sample. After reaction for 6 min at room temperature, the absorbance at 734 nm was measured. VC was used as the positive control, and the ABTS radical scavenging ability was calculated according to the following equation:
ABTS radical scavenging activity (%)= 1-
Where A 0 is the absorbance of the control (water instead of the sample), A 1 is the absorbance of the sample, and A 2 is the absorbance of the sample only (PBS instead of ABTS).
Assay of hydroxyl radical scavenging activity
This assay was performed using the published method with slight modifications (25) .
In brief, 1 mL of FeSO 4 (9 mM), 1 mL of 9 mM ethanol solution of salicylic acid, and 1 mL H 2 O 2 (8 mM) were mixed with 1 mL of sample. After reaction at 37 °C for 30 min, the absorbance at 510 nm was measured. VC was used as the positive control and the hydroxyl radical scavenging ability was calculated according to the following equation:
Hydroxyl radical scavenging activity (%)= 1-
Where A 0 is the absorbance of the control (water instead of the sample), A 1 is the absorbance of the sample, and A 2 is the absorbance of the sample only (water instead of H 2 O 2 ).
Assay of superoxide radical scavenging activity
The ability to scavenge the superoxide radical was determined as previously 
Body weight measurement and organ indexes
The mice were weighed every 2 days. On the last day of the experimental period, after 8-12 h of fasting, the mice were sacrificed under ether narcotization, based on the methods described by Tu et al. (4) . The brain, spleen, and thymus were isolated and weighed to calculate the organ coefficients, using the following formula: coefficient (mg/g) = organ weight (mg)/body weight (g).
Biochemical examinations of MDA, PC, and GSH levels in serum
All the mice were anesthetised and 0.5-0.6 mL of peripheral blood was drawn through the angular vein. (27) Blood samples were placed in centrifuge tubes and clotted for 30 min at room temperature, then centrifuged at 5000 rpm for 20 min at 4 °C.
Finally, the supernatant was separated for biochemical analysis of MDA, PC, and GSH levels based on the manufacturer's instructions for the kits.
Assessment of oxidative status in brain
A random subset of brain samples (nine per group) were collected and homogenized in volumes of ice-cold physiological saline to obtain a 10% (w/v) homogenate with 10 strokes at 4000 rpm in a Bioprep-6 homogenizer (Hangzhou Allsheng Instruments Co., Ltd., Hangzhou, China). According to the preparation of brain homogenates by Xu et al. (5) , the homogenates were directly centrifuged at 2500 rpm at 4 °C for 10 min, and the supernatants were obtained to determine MDA, PC, and T-AOC levels; SOD, MAO, GSH-PX, NOS, and AchE activities; and GSH, NO, Ach, DA, and NE contents, according to the corresponding instructions for the kits. Protein concentrations were measured using a commercially available BCA protein assay kit and using bovine serum albumin as a standard.
Determination of neuropathological alterations in the brain
For histological analysis, the brain tissue of three randomly selected mice from different groups were fixed in a fresh solution of 4% paraformaldehyde (pH 7.4) at 4 °C for 24 h, followed by embedment in paraffin and longitudinal sectioning. Then, 5-μm-thick sections were obtained for hematoxylin-eosin (H&E) staining. The stained slides were viewed by microscopy for histopathological analysis.
The method for preparing the brain homogenate was the same as in 2.4.4. The supernatants were obtained to determine iNOS activity and NO content based on the manufacturer's instructions for the kits.
Statistical analysis
The experimental data were analyzed by PASW statistics 18 software and subjected to one-way analysis of variance (ANOVA), followed by LSD tests for multiple comparisons. All data were presented as the mean ± SD, and values of P＜0.05 and P＜ 0.01 were considered statistically significant.
Results
The main compositions of PYEDE
As shown in Table 1 , the major constituents of PYEDE were polysaccharides and proteins. The carbohydrate and protein contents were 222.9 and 211.6 mg/g, respectively. The contents of reducing sugar, sulphuric radical, amino acids, uronic acid, and phenolic compounds and were assayed as 132.2 mg, 122.5 mg, 62.3 mg, 19.5 mg, and 6.9 mg per 1 g PYEDE, respectively.
In vitro antioxidant activity of PYEDE
The four widely used assays were performed to measure the antioxidant activity of PYEDE in vitro, and the results are displayed in Figure 1 . The IC 50 value was measured as the concentration required to scavenge 50% of the radicals.
The DPPH and ABTS free radicals are widely used indicators of the preliminary radical scavenging capacity of antioxidant compounds (26) Accepted manuscript radical scavenging abilities.
The superoxide radical is considered as the primary ROS, and the hydroxyl radical is a typical representative of harmful secondary ROS that can cause oxidative injury and cell damage (5) . As shown in Figures 1C and 1D , the antioxidant capacities of PYEDE and VC increased in a concentration-dependent manner. The IC50 values of hydroxyl and superoxide radicals of VC were found to be 0.136 and 0.019 mg/mL, respectively.
Whereas that of PYEDE were 2.938 and 4.656 mg/mL, respectively. PYEDE exhibited greater hydroxyl and superoxide radicals scavenging capacities compared with VC. As a result, the antioxidant activities of PYEDE were further investigated.
Effect of PYEDE on D-gal-induced aging model mice
Effect of PYEDE on body weight and organ indexes
Morphological changes are inevitable during the aging process (28) . As shown in Figure 2B ). In contrast, after treatment with VC and PYEDE, the phenomena were substantially alleviated. Overall, the results suggested that to a certain extent, the administration of PYEDE protected against weight loss and organ atrophy. and PC levels and an increase in GSH content in the serum (P＜0.05 or P＜0.01). These findings suggested that PYEDE attenuated D-gal-induced lipid peroxidation and protein carbonylation, and improved the ability of the mice to defend against antioxidants.
Effect of PYEDE on MDA, PC, and GSH levels in serum
Effect of oxidative status in the brain
Numerous studies have proved that antioxidant activity plays an indispensable role in the biological aging process (3) . Thus, we further investigate several key antioxidants that can scavenge ROS, including the enzymatic antioxidants GSH-Px and SOD and the non-enzymatic antioxidant T-AOC in the brain. The differences in the brain antioxidant parameters between the treatment groups are shown in of T-AOC and GSH. These results collectively indicated that PYEDE protected against oxidative stress damage induced by D-gal.
Analysis of PYEDE on brain neuropathological alterations
The CA1 region of the hippocampus is known to be vital for learning and memory, and the neurogenesis in the hippocampus declines with aging, along with a continuous loss of neurons (31) . As depicted in Figure 4A , no pathological alterations were evident in the BC group, the nerve fibers and neurons were arranged regularly and tightly, and the nuclei were large, round, and lightly stained in the CA1 region of the hippocampus.
In contrast, there were some neuropathological changes in the DM group, including a reduction of the CA1 pyramidal cell layer, irregular nerve fibers, and loosely arranged neurons, accompanied by atrophy or disappearance. After administration of VC and PYEDE, the morphology of the nerve fibers and neurons visibly improved compared with the DM group; there was an obvious increase in round-shaped neurons with regular nerve fibers, and neurons were more compactly and orderly arranged. The effect of PYEDE at high dose (300 mg/kg) appeared similar to those in the BC and VC groups.
In addition, the iNOS activity and NO content, which lead to neurodegenerative diseases, markedly increased (P＜0.01) in D-gal-induced mice compared with normal mice ( Figure 4B ). After administration of PYEDE and VC, the iNOS activity and NO content significantly downregulated compared with those in the DM group. The results suggested that PYEDE attenuated neurodegenerative diseases caused by oxidative stress and improved cognitive ability. The symptoms of neurodegenerative diseases include memory impairment, the loss of cognitive ability, and dyskinesia. It is well documented that these symptoms are also associated with the disorders of the metabolism of cholinergic and monoamine neurotransmitters (2, 32) . Therefore, we studied the effect of PYEDE on the AchE activity and Ach content of the cholinergic nervous system and the MAO activity and DA and NE contents of monoamine neurotransmitters. Figure 5 reveals the data on neuroprotection in the mice brain. Long-term D-gal injection in mice caused a 1.20-fold increase in AchE enzymatic activity (P＜0.01) ( Figure 5A 
Discussions
Aging is a major cause of physiological dysfunctions, including central nervous system degeneration, cognitive deterioration, and the massive loss of neurons. With the increasing population and prolongation of lifespans, aging has become a worldwide problem and anti-aging has become an important public issue (3, 28) . The brain accounts for 20% of the total oxygen consumption of the body, it is prone to a lack of antioxidant enzymes and produces relatively more ROS compared with other tissues with low oxygen consumption (33) . There is considerable evidence that oxidative stress plays an Accepted manuscript important role during the pathogenesis of age-associated or neurodegenerative diseases.
An imbalance between the generation of oxidants and the antioxidant defenses of the body leads to oxidative damage of cells and tissues, modifying their morphology and function and resulting in aging and premature cell death (4, 5) . The D-gal-induced aging model is based on the metabolic and free radical theories of aging, and is similar to the natural aging process (8, 29) . Therefore, the chronic D-gal-induced aging of mice has been widely used in anti-aging pharmacology studies. This model was used to investigate supplements and antioxidants that have the potential to treat brain damage caused by aging.
P. yezonensis is a macroalga with high nutritive value that is mainly distributed in
Asia; numerous studies have reported that the cell wall of red algae is mainly composed of an abundance of polysaccharides, such as agar, cellulose, and pectin (10) . In this study, we used agarase, cellulase, and pectinase to degrade the cell wall of P. yezonensis, as, compared with other methods, the intracellular components can be released more effectively, resulting in increased dissolution of active and nutritional ingredients. We used four classic established in vitro antioxidant systems to evaluate the antioxidant properties of PYEDE. Our study found that PYEDE had significant scavenging abilities on DPPH, ABTS, hydroxyl, and superoxide radicals, proving that PYEDE has antioxidant potential. This activity can be attributed to the composition of PYEDE.
Previous studies have explored the ability of P. yezoensis polysaccharides to prevent acute chemical liver injury induced by CCl 4 in mice (11) . Previous investigations have verified that C-phycoerythrin is involved in the amelioration of diabetic complications by significant reductions in oxidative stress (12) . In addition, some phenolic compounds have strong antioxidant properties (23) .
To further confirm the potential of PYEDE as an antioxidant, we established an aging model by subcutaneous injections of D-gal into female ICR mice for 10 weeks to investigate the protective effect of PYEDE on brain injury and neurodegenerative diseases induced by D-gal. Previous studies have shown that the most easily assessed features of the aging process are the morphological changes in appearance, and D-gal can accelerate these features (34) . In our study, before the intervention treatment, the body weight of normal mice was higher than the D-gal-treated-mice, and we were able to effectively alleviate weight loss after PYEDE intervention treatment. The D-gal-induced aging model group showed slow weight loss, which was similar to the results of previous studies (32, 35) . The brain is an important part of the central nervous system and the main regulator of vital functions. In addition, the spleen and thymus are considered to be indispensable immune organs, and spleen and thymus indexes can reflect the immune function of the body and are precise indicators of biological aging (36) . There same There were significant decreases in body weight and organ indexes of brain, spleen, and thymus indexes after administration of D-gal, and similar consequences have been found in previous studies (28, 37) . In our study, PYEDE effectively alleviated weight loss and organ atrophy, suggesting that PYEDE protected the brain from atrophy and slowed aging by strengthening immune functions.
Oxidative stress caused by ROS is the major driving force of brain damage, as it may directly oxidize lipids and proteins and indirectly induce oxidant/antioxidant imbalances by disrupting the activity of enzymes (28) . It is well documented that D-gal-induced oxidative damage can be evaluated by measuring the activities of antioxidant enzymes (GSH-Px, SOD, MAO, and T-AOC) and the levels of MDA, PC, and GSH (3, 8, 38) . As one of the most important members of the antioxidant defense system, SOD can catalyze the superoxide radical to form H 2 O 2 , which can be further metabolized by GSH-Px. GSH is a significant antioxidant and free radical scavenger in the body; it can react with H 2 O 2 to form GSSH under the catalysis of GSH-Px and remove peroxide and hydroxyl radicals produced by cellular respiratory metabolism (30, 39) . T-AOC has comprehensive antioxidant capacities, whereas MDA is a by-product of lipid peroxidation induced by free radicals, and its content indirectly reflects the level of lipid peroxidation in the body. The generation of PC is an important marker of the oxidative modification of protein molecules by free radicals. The level of PC is closely related to aging, and is often used to indicate the extent of oxidative damage in proteins (29, 40) . In the present study, after treatment with PYEDE, MDA and PC levels were clearly reduced and the content of GSH remarkably elevated in serum. Serum is the most intuitive indicator of physical status, suggesting that PYEDE could protect the mice against D-gal-induced oxidative stress. Oxidative damages is a crucial factor which contributing to brain aging and senile dementia (2) . Furthermore, we observed that administration of PYEDE improved the antioxidant activities of GSH-Px, SOD, and T-AOC and the level of GSH, as well as reduced MDA and PC levels in the brain. These results were similar to those of a study on carnosine and taurine (40) in which PYEDE substantially inhibited the occurrence of oxidative damage in the brain. In addition, the protective antioxidant effects of a P. yezonensis polysaccharide in CCl 4 hepatotoxicity have been reported (11) . These data provide evidence that the bioactivities of P.
yezonensis could be used to prevent oxidative stress.
NO is considered as an important diffusion signal in brain development, learning, and memory, but excessive production of NO is cytotoxic, causing nerve damage and encephalopathy (41) . NO is synthesized by at least three isozymes (inducible NOS, neuronal NOS, and endothelial NOS). In contrast to neuronal NOS (nNOS) and endothelial NOS (eNOS), which are known as constitutive NOS (cNOS), inducible NOS (iNOS) is not expressed in the brain under normal physiological conditions and has been proven to be an inhibitory molecule of neuron regeneration in the hippocampus (42, 43) . Our study demonstrated that iNOS activity and NO content were upregulated in D-gal-induced mice. In addition, histopathological analysis revealed a reduction of the pyramidal cell layer and severe damage to neurons, accompanied by irregular nerve fibers in the hippocampus CA1 region in D-gal treated mice brain, and the findings were consistent with previous studies (5, 36) . PYEDE treatment can effectively inhibit the activity of iNOS, reduce the content of NO, and alleviate damage to the hippocampus and brain atrophy, possibly by renewing the ability of the brain to scavenge ROS (in vitro) and reducing lipid peroxidation and protein carbonylation.
Previous studies have shown that inhibition of iNOS and NO generation can attenuate hippocampal neuronal apoptosis, and an ethanol extract of P. yezoensis promoted the development of hippocampal neurons by enhancing the rates of early neuronal differentiation and axodendritic arborization (44, 45) . Another study demonstrated that D-gal affected inflammatory markers, such as iNOS, causing them to activate the NF-κB pathway (3) . At present, the pathogenesis and etiology of many neurodegenerative diseases are not fully understood; however, many researchers believe that a reduction of neurons is one of the main pathogeneses, and this mechanism is targeted in the search for improved methods and drugs.
The metabolism of neurotransmitters plays a crucial role in the regulation of the neuroendocrine network, and alterations in multiple neurotransmitter systems may be associated with the pathogenesis of age-related brain degenerative disorders such as Alzheimer's disease (2, 46) . The complex etiology of Alzheimer's disease has encouraged active research into developing multi-target drugs with two or more complementary biological activities. The development novel inhibitors of AchE and MAO is a promising direction for the treatment of Alzheimer's disease (47) . AchE and MAO are enzymes revelent to cholinergic and monoaminergic neurotransmitters, respectively.
AchE is an important regulatory enzyme that controls the transmission of nerve impulses across cholinergic synapses by hydrolyzing Ach to choline and acetate (48) .
Increased activity of AchE is associated with the formation of amyloid plaques in the brain, and increased levels of beta-amyloid (Aβ) can, eventually, cause degeneration of cholinergic nerve terminal function in the hippocampus and cholinergic neuron atrophy, causing disruption of neurotransmission and eventually triggering Alzheimer's disease (49) (50) (51) . MAO is an important enzyme of the outer mitochondrial membrane and the central nervous system that catalyzes the degradation of a wide range of monoamine neurotransmitters, including DA and NE (29, 35) . It is assumed that activation of MAO is associated with the generation of free radicals in the involution of the nervous tissue (52) .
In the present study, increased AchE and MAO activities led to a reduction of Ach and monoamine neurotransmitters in the brains of D-gal-induced-mice, whereas PYEDE reduced the activities of AchE and MAO and increased the contents of Ach, DA, and NE. Thus, the neuroprotective effects of PYEDE involved modulation of the activities of enzymes related to neurotransmitter metabolism. Numerous studies have also shown that improvements in learning and memory of aged mice were achieved by increasing NE and DA levels and decreasing the activity of AchE (53) (54) (55) . The polysaccharides of PYEDE might have played a role in the neuroprotective effects, and this is supported by previous studies (56) that found that oligosaccharides or sulphated oligosaccharides extracted from seaweed, such as GV-971, captured Aβ at multiple sites, and inhibited Aβ fibrils formation, and improved cognitive impairment. Moreover, oxidative damage induced by free radicals was an important factor in neuronal degeneration and promoted the appearance of Aβ and neurofibrillary changes (39) . Thus, the neuroprotective effects of PYEDE were also achieved by reversing the decline of the antioxidant defense, which was confirmed by the data above. However, the imbalance in neurotransmitters which are synthesized within the neurons, led to synaptic damage and neuronal cell loss relevant to memory function (54) , which is similar to the phenomenon observed in our study. Therefore, it seems that PYEDE ameliorated the cell components of the oxidative damaged brain and restored neuronal activity, including the synthesis and transport of neurotransmitters and enzymes, which is consistent with hippocampal pathology.
Conclusions
In summary, the results of our study support the hypothesis that treatment with PYEDE could alleviate oxidative-stress-induced damage in neurodegenerative diseases.
Our findings demonstrated that PYEDE exerted a strong antioxidant effect in vitro and effectively protected against brain injury in D-gal-treated mice. The underlying protective mechanisms might involve the improvement in organ atrophy, inhibition of lipid peroxidation and protein carbonylation, renewal of antioxidant enzymes activities, amelioration of hippocampal neuronal apoptosis and damage, and beneficial modulation of multiple neurotransmitter systems. This study provides novel insights into PYEDE as an effective mediator of age-related cognitive deficits and supports the use of a multitarget approach in the treatment of neurodegenerative diseases.
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